Sign in Subscribe
Class action lawsuits

Alto Neuroscience Class Action Lawsuit: Investors Reminded of Deadline

Strategic Insights

— 1 min read

Investors who purchased common stock of Alto Neuroscience, Inc. (NYSE: ANRO) may be eligible for compensation due to alleged misleading statements made by the company regarding its business, operations, and prospects. A class action lawsuit has been filed, and the deadline for lead plaintiff designation is September 19, 2025. The lawsuit claims that defendants made false and/or misleading statements and/or failed to disclose the ineffectiveness of ALTO-100 in treating major depressive disorder, among other issues.

Key Takeaways:

  • The lawsuit alleges that Alto Neuroscience made false and/or misleading statements regarding its business, operations, and prospects.
  • The offering documents and defendants allegedly failed to disclose the ineffectiveness of ALTO-100 in treating major depressive disorder.
  • The lawsuit claims that investors suffered damages when the true details of the company's business and financial prospects were revealed.
  • Investors who purchased Alto securities may be entitled to compensation without payment of any out-of-pocket fees or costs.
  • The Rosen Law Firm, a global investor rights law firm, is representing investors in the class action lawsuit.
  • The firm has achieved significant securities class action settlements and has a track record of success in leadership roles.
  • The lawsuit allows investors to serve as lead plaintiff and direct the litigation.

Statistics:

  • The class action lawsuit was filed on an unspecified date.
  • The deadline for lead plaintiff designation is September 19, 2025.
  • Alto Neuroscience's stock was trading on the NYSE under the ticker symbol ANRO.
  • The lawsuit claims that Alto Neuroscience made materially false and misleading statements regarding its business and prospects.
  • The firm achieved the largest ever securities class action settlement against a Chinese Company at the time.

Sources:

  • Newsfile Corp. - (Newsfile Corp. - September 15, 2025)
  • The Rosen Law Firm, P.A, 275 Madison Avenue, 40th Floor New York, NY 10016, Tel: (212) 686-1060, Toll Free: (866) 767-3653, Fax: (212) 202-3827, case@rosenlegal.com, www.rosenlegal.com

Read more